Shares of SWEDISH ORPHAN/S (OTCMKTS:SWTUY – Get Free Report) fell 1.2% on Tuesday. The company traded as low as $24.38 and last traded at $24.38. 200 shares changed hands during trading, a decline of 88% from the average daily volume of 1,665 shares. The stock had previously closed at $24.67.
SWEDISH ORPHAN/S Stock Performance
The stock’s 50-day moving average price is $24.38 and its 200-day moving average price is $24.38. The company has a market capitalization of $6.64 billion, a price-to-earnings ratio of 48.76, a P/E/G ratio of 1.30 and a beta of 1.81.
SWEDISH ORPHAN/S Company Profile
Swedish Orphan Biovitrum AB, known as Sobi, is a Sweden-based biopharmaceutical company focused on developing, manufacturing and commercializing specialty medicines for rare diseases. Its principal areas of activity include hematology, immunology and other conditions in which treatment options are limited or unmet medical needs remain significant.
The company’s portfolio includes therapies for disorders such as hemophilia and other bleeding conditions, as well as treatments for immune-mediated diseases and selected rare inflammatory conditions.
Further Reading
- Five stocks we like better than SWEDISH ORPHAN/S
- A Chinese Rival Just Spooked Memory Stocks—How Worried Should Micron Investors Be?
- Could T-Mobile’s Satellite Competition Fears Create a Buying Opportunity?
- Surgical Precision, Sustainable Returns: Johnson & Johnson Secures Its Cash Flow Runway
- Tesla’s Robotaxi Lands in Paris—But Europe’s Real Fight Is Over Cheap EVs
Receive News & Ratings for SWEDISH ORPHAN/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SWEDISH ORPHAN/S and related companies with MarketBeat.com's FREE daily email newsletter.
